Tag: 57.5M

Imbria Pharmaceuticals Raises $57.5M in Series B Financing

Imbria Pharmaceuticals, Inc., a Boston, MA-based scientific stage biotechnology firm creating novel therapies for cardiometabolic ailments with excessive…